LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment
This open access special report, brought to MedChemNet users by our sister journal Future Medicinal Chemistry, provides an introduction to the first-in-class oncolytic peptide termed LTX-315.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.